Antimicrobial Agents and Chemotherapy

It’s vital to optimize use of antimicrobials Optimize antimicrobial use to confirm effectiveness whereas minimizing resistance development in common community-acquired infections Identify management ways to stop, or minimize clinically important drug interactions with common antimicrobials. Safety and effectiveness of intravenous iron in patients with chemotherapy- elicited anemia receiving darbepoetin alfa Effects of endovenous (IV) iron supplementation on responses to every-three-week (Q3W) darbepoetin alfa (DA) by baseline hemoglobin in patients (pts) with chemotherapy-induced anemia (CIA)1 A phase III clinical trial randomised controlled study comparison iron saccharose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing therapy and glycoprotein stimulating agent (ESA) therapy Improvement in quality of life precedes increase in hemoglobin levels upon treatment with intravenous iron and epoetin alfa.

  • Antimicrobials, diagnostics and infection control

Related Conference of Antimicrobial Agents and Chemotherapy

June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

Singapore
October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
November 05-06, 2020

9th Asia Pacific STD and Infectious Diseases Congress

Tokyo, Japan
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
February 22-23, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore

Antimicrobial Agents and Chemotherapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in